SECTION 1 - CHEMICAL PRODUCT AND COMPANY IDENTIFICATION |
MSDS Identification:
- Key: 99112
- Name: Lead (II) Fluoride, Powder, ca. 5 Micron, 98+%
Catalog Numbers:
AC318290000, AC318291000
Synonyms:
SUPPLIER: ZHANGJIANG DONGYAN GALT FINE CHEMCAL CO., LTD.
BUSINESS TEL: ++86-579-6530757
FACSIMILE: ++86-579-6530756
SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS |
CAS # |
Chemical Name |
% |
7783-46-2 |
Lead (II) Fluoride |
98+% |
Hazard Symbols: T
Risk Phrases: 20/22 33 61 62
| SECTION 3 - HAZARDS IDENTIFICATION |
EMERGENCY OVERVIEW
Appearance: beige and gray crystals. Danger! Causes eye and skin irritation. May cause respiratory and digestive tract irritation. This product contains lead, a chemical known to the state of California to cause cancer. This product contains lead, a chemical known to the state of California to cause developmental effects. May cause skeletal abnormalities. Danger of cumulative effects.
Target Organs: Central nervous system, skeletal structures.
POTENTIAL HEALTH EFFECTS
Eye: May cause eye irritation. May cause visual disturbances.
Skin: Causes skin irritation.
Ingestion: May cause gastrointestinal irritation with nausea, vomiting and diarrhea. Inorganic fluorides can be harmful. Acute exposure to fluorine compounds can lead to digestive tract burns, and abdominal pain. Exposure to fluoride compounds can result in systemic toxic effects on the heart, liver, and kidneys. It may also deplete calcium levels in the body leading to hypocalcemia and death. Fluoride can reduce calcium levels leading to fatal hypocalcemia. Ingestion of lead compounds can cause toxic effects in the blood-forming organs, kidneys and central nervous system. Symptoms of lead poisoning or plumbism include weakness, weight loss, lassitude, insomnia, and hypotension. It also includes constipation, anorexia, abdominal discomfort and colic. Symptoms of lead poisoning include; weakness, weight loss, lassitude, insomnia, and hypotension. Acute lead poisoning can cause muscle weakness, "lead line" on the gums, metallic taste, definite loss of appetite, insomnia, dizziness, high lead levels in blood and urine with shock, coma and death in extreme cases. The most severe lead exposure may result in encephalopathy. Exposure may result in headaches and insomnia, persistent vomiting, irritability, restlesnesness, delirium, hallucinations, convulsions, and coma. In any type of plumbism (lead poisoning), the patient may show facial pallor, gingival lead line, mild jaundice, anemia, basophilic stippling of red blood cells, albuminuria, cylinduria, porphyrinuria and excessive urinary and blood concentrations of lead. Acute poisoning by ingestion of lead compounds may result in an astringent and metallic taste in the mouth, dry throat, and thirst. It may also result in a burning abdominal pain, nausea, and vomiting. Other symptoms include diarrhea with the presence of bloody stools, shock. There may be CNS effects including: headache, insomnia, paresthesias, depression, coma, and death. There may be
kidney damage including: oliguria, albiminuria, and cylinduria. Lead is a cumulative poison. Increasing amounts build up in the body and eventually reach a point where symptoms and disability occur.
Inhalation: May cause respiratory tract irritation. May cause effects similar to those described for ingestion.
Chronic: Chronic inhalation and ingestion may cause chronic fluoride poisoning (fluorosis) characterized by weight loss, weakness, anemia, brittle bones, and stiff joints. Effects may be delayed. Chronic exposure to lead may result in plumbism which is characterized by lead line in gum, headache, muscle weakness, mental changes. Chronic exposure to fluoride compounds may cause systemic toxicity. Chronic expsoure to lead may cause adverse effects on human reproduction, embryonic and fetal development and postnatal (e.g., mental) development.
| SECTION 4 - FIRST AID MEASURES |
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin: Get medical aid. Flush skin with plenty of soap and water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion: Do NOT induce vomiting. If victim is conscious and alert, give 2-4 cupfuls of milk or water. Never give anything by mouth to an unconscious person. Get medical aid.
Inhalation: Remove from exposure to fresh air immediately. If not breathing, give artificial respiration. Get medical aid. Do NOT use mouth-to-mouth resuscitation.
Notes to Physician: Use of chelators such as BAL penicillamine and N-acetylpenicillamine should be considered.
Antidote: There exists several chelation agents. The determination of there use should be made only by qualified medical personnel.
| SECTION 5 - FIRE FIGHTING MEASURES |
General Information: As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Use water spray to keep fire-exposed containers cool. Contact with metals may evolve flammable hydrogen gas. Containers may explode when heated. Non-combustible, substance itself does not burn but may decompose upon heating to produce irritating, corrosive and/or toxic fumes.
Extinguishing Media: Do NOT get water inside containers. For small fires, use dry chemical, carbon dioxide, or water spray. For large fires, use dry chemical, carbon dioxide, alcohol-resistant foam, or water spray. Cool containers with flooding quantities of water until well after fire is out.
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
NFPA Rating: (estimated) Health: 2; Flammability: 0; Instability: 0
| SECTION 6 - ACCIDENTAL RELEASE MEASURES |
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks: Vacuum or sweep up material and place into a suitable disposal container. Avoid runoff into storm sewers and ditches which lead to waterways. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions. Provide ventilation.
| SECTION 7 - HANDLING AND STORAGE |
Handling: Wash thoroughly after handling. Wash hands before eating. Use only in a well-ventilated area. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation. Wash clothing before reuse.
Storage: Keep from contact with oxidizing materials. Store in a cool, dry, well-ventilated area away from incompatible substances. Keep containers tightly closed.
| SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION |
Engineering Controls: Use process enclosure, local exhaust ventilation, or other engineering controls to control airborne levels below recommended exposure limits. Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower.
EXPOSURE LIMITS
Chemical Name |
ACGIH |
NIOSH |
OSHA - Final PELs |
Lead (II) Fluoride |
0.05 mg/m3 TWA(listed under **no name **). |
0.050 mg/m3 TWA(listed under **no name **).0.050mg/m3 TWA (as Pb)(listed under **no name **).100mg/m3 IDLH(listed under **no name **).100mg/m3 IDLH (asPb) (listedunder ** no name**). |
2.5 mg/m3 TWA(as F) (listedunder ** no name**).as Pb: 50ug/m3 TWA PEL;30 ug/m3 actionlevel; Poison(see 29 CFR1910.1025)(listed under** no name **). |
OSHA Vacated PELs:
Lead (II) Fluoride: 2.5 mg/m3 TWA (listed under ** no name **)
PERSONAL PROTECTIVE EQUIPMENT
Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin: Wear appropriate protective gloves and clothing to prevent skin exposure.
Clothing: Wear appropriate protective gloves and clothing to prevent skin exposure.
Respirators: A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant a respirator's use.
| SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES |
Physical State: Crystals
Color: beige and gray
Odor: none reported
pH: Not available.
Vapor Pressure: Not available.
Vapor Density: Not available.
Evaporation Rate: Not available.
Viscosity: Not available.
Boiling Point: 1293 deg C @ 760.00mmHg
Freezing/Melting Point: 824 deg C
Decomposition Temperature:
Solubility in water: 0.065 G/100 ML WATER (20)
Specific Gravity/Density: 8.4450g/cm3
Molecular Formula: F2Pb
Molecular Weight: 245.19
| SECTION 10 - STABILITY AND REACTIVITY |
Chemical Stability: Stable at room temperature in closed containers under normal storage and handling conditions.
Conditions to Avoid: Incompatible materials, dust generation, excess heat, strong oxidants.
Incompatibilities with Other Materials: Acids, hydrogen peroxides, strong oxidizing agents, calcium carbide, fluorine.
Hazardous Decomposition Products: Hydrogen fluoride, lead/lead oxides.
Hazardous Polymerization: Has not been reported
| SECTION 11 - TOXICOLOGICAL INFORMATION |
RTECS#:
- CAS# 7783-46-2: OG1225000
LD50/LC50:
- CAS# 7783-46-2: Oral, mouse: LD50 = 3015 mg/kg; Oral, rat: LD50 = 3031 mg/kg.
Carcinogenicity:
Lead (II) Fluoride -
- ACGIH: A3 - Animal Carcinogen (listed as ** undefined **).
- California: carcinogen; initial date 10/1/92 (listed as ** undefined * OSHA: Possible select carcinogen (listed as ** undefined **).
- IARC: Group 3 carcinogen (listed as ** undefined **).
Epidemiology:
Epidemiological studies have not shown a relationship between lead exposure and the incidence of cancer in lead workers. A study involving battery plant workers showed a significant rise in the standardized mortatility ratio for gastric and lung cancer IARC has concluded that the evidence for carcinogenicity of lead to humans is inadequate although there is sufficient evidence of carcinogenicity of some lead salts to animals. Repeated exposure to lead has caused many toxic effects including: neurological changes, kidney damage, and blood abnormalities. There are several reports that certain l
Teratogenicity:
No information found.
Reproductive Effects:
Reproductive effects have occurred in experimental animals.
Neurotoxicity:
Neurotoxic effects have occurred in humans. Neurotoxic effects have occurred in experimental animals.
Mutagenicity:
No information found.
Other Studies:
See actual entry in RTECS for complete information.
SECTION 12 - ECOLOGICAL INFORMATION |
| SECTION 13 - DISPOSAL CONSIDERATIONS |
Chemical waste generators must determine whether a discarded chemical is classified as a hazardous waste. US EPA guidelines for the classification determination are listed in 40 CFR Parts 261.3. Additionally, waste generators must consult state and local hazardous waste regulations to ensure complete and accurate classification.
RCRA P-Series: None listed.
RCRA U-Series: None listed.
| SECTION 14 - TRANSPORT INFORMATION |
US DOT
- Shipping Name: LEAD COMPOUNDS, SOLUBLE, N.O.S.
- Hazard Class: 6.1
- UN Number: UN2291
- Packing Group: III
Canadian TDG
- No information available.
SECTION 15 - REGULATORY INFORMATION |
TSCA
- CAS# 7783-46-2 is listed on the TSCA inventory.
Health & Safety Reporting List
- None of the chemicals are on the Health & Safety Reporting List.
Chemical Test Rules
- None of the chemicals in this product are under a Chemical Test Rule.
Section 12b
- None of the chemicals are listed under TSCA Section 12b.
TSCA Significant New Use Rule
- None of the chemicals in this material have a SNUR under TSCA.
SARA
CERCLA Hazardous Substances and corresponding RQs
- CAS# 7783-46-2: 10 lb final RQ; 4.54 kg final RQ
SARA Section 302 Extremely Hazardous Substances
- None of the chemicals in this product have a TPQ.
Section 313
- This material contains Lead (II) Fluoride (listed as ** undefined **), 99%, (CAS# 7783-46-2) which is subject to the reporting requirements of Section 313 of SARA Title III and 40 CFR Part 372.
Clean Air Act:
- CAS# 7783-46-2 listed as ** no name ** is listed as a hazardous air pollutant (HAP).
- This material does not contain any Class 1 Ozone depletors.
- This material does not contain any Class 2 Ozone depletors.
Clean Water Act:
- CAS# 7783-46-2 is listed as a Hazardous Substance under the CWA.
- CAS# 7783-46-2 is listed as a Priority Pollutant under the Clean Water Act.
- CAS# 7783-46-2 is listed as a Toxic Pollutant under the Clean Water Act.
OSHA:
- None of the chemicals in this product are considered highly hazardous by OSHA.
Lead (II) Fluoride can be found on the following state right to know lists: California, New Jersey, Florida, (listed as ** no name **), Pennsylvania, Minnesota, (listed as ** no name **), Minnesota, (listed as ** no name **), Minnesota, (listed as ** no name **), Massachusetts.
The following statement(s) is(are) made in order to comply with the California Safe Drinking Water Act:
- WARNING: This product contains Lead (II) Fluoride, listed as ` ** undefined **', a chemical known to the state of California to cause cancer.
- WARNING: This product contains Lead (II) Fluoride, listed as ` ** undefined **', a chemical known to the state of California to cause birth defects or other reproductive harm.
California No Significant Risk Level: None of the chemicals in this product are listed.
European/International Regulations
European Labeling in Accordance with EC Directives
- Hazard Symbols: T
- Risk Phrases:
- R 20/22 Harmful by inhalation and if swallowed.
- R 33 Danger of cumulative effects.
- R 61 May cause harm to the unborn child.
- R 62 Possible risk of impaired fertility.
- S 53 Avoid exposure - obtain special instructions before use.
- S 45 In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible).
WGK (Water Danger/Protection)
United Kingdom Occupational Exposure Limits
- CAS# 7783-46-2: OES-United Kingdom, TWA (listed as ** undefined **): 2.5 mg/m3 TWA (inorganic, as F)
United Kingdom Maximum Exposure Limits
Canada
- CAS# 7783-46-2 is listed on Canada's DSL List.
- This product has a WHMIS classification of D1B, D2A, D2B.
- CAS# 7783-46-2 is not listed on Canada's Ingredient Disclosure List.
Exposure Limits
- CAS# 7783-46-2: OEL-ARAB Republic of Egypt:TWA 0.05 mg(Pb)/m3
- OEL-AUSTRALIA:TWA 0.15 mg(Pb)/m3
- OEL-AUSTRALIA:TWA 2.5 mg(F)/m3
- OEL-AUSTRIA:TWA 0.1 mg(Pb)/m3
- OEL-BELGIUM:TWA 0.15 mg(Pb)/m3
- OEL-BELGIUM:TWA 2.5 mg(F)/m3
- OEL-CZECHOSLOVAKIA:TWA 1 mg(F)/m3;STEL 5 mg(F)/m3
- OEL-DENMARK:TWA 0.1 mg(Pb)/m3
- OEL-DENMARK:TWA 2.5 mg(F)/m3
- OEL-FINLAND:TWA 0.1 mg(Pb)/m3
- OEL-FINLAND:TWA 2.5 mg(F)/m3
- OEL-FRANCE:TWA 0.15 mg(Pb)/m3
- OEL-FRANCE:TWA 2.5 mg(F)/m3
- OEL-GERMANY:TWA 0.1 mg(Pb)/m3
- OEL-GERMANY:TWA 2.5 mg(F)/m3
- OEL-HUNGARY:STEL 0.04 mg(Pb)/m3;Carcinogen
- OEL-HUNGARY:TWA 1 mg(F)/m3;STEL 2 mg(F)/m3
- OEL-THE NETHERLANDS:TWA 2.5 mg(F)/m3
- OEL-THE PHILIPPINES:TWA 0.15 mg(Pb)/m3
- OEL-THE PHILIPPINES:TWA 2.5 mg(F)/m3
- OEL-POLAND:TWA 1 mg(F)/m3
- OEL-RUSSIA:STEL 0.005 ppm (0.01 mg(Pb)/m3)
- OEL-SWEDEN:TWA 0.05 mg(Pb)/m3 (resp. dust)
- OEL-SWEDEN:TWA 0.1 mg(Pb)/m3 (total dust)
- OEL-SWEDEN:TWA 2 mg(F)/m3
- OEL-SWITZERLAND:TWA 0.1 mg(Pb)/m3
- OEL-SWITZERLAND:TWA 1.8 ppm (1.5 mg(F)/m3);STEL 9.0 ppm
- OEL-THAILAND:TWA 0.2 mg(Pb)/m3
- OEL-THAILAND:TWA 2.5 mg(F)/m3
- OEL-TURKEY:TWA 0.2 mg(Pb)/m3
SECTION 16 - ADDITIONAL INFORMATION |
MSDS Creation Date: 9/02/1997, Revision #4 Date: 3/18/2003
The information above is believed to be accurate and represents the best information currently available to us. However, we make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for their particular purposes. In no way shall the company be liable for any claims, losses, or damages of any third party or for lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if the company has been advised of the possibility of such damages |